The first case of thalassaemia, described in a non-Mediterranean person, was from India.
Subsequently, cases of thalassaemia were documented in all parts of India. Centres for care …

The success of transplant procedures in patients with beta-thalassemia major (β-
thalassemia) goes hand-in-hand with improvements in disease knowledge, better …

Severe blood disorders and cancer are the leading cause of death and disability from
noncommunicable diseases in the global pediatric population and a major financial burden …

The literature describing tuberculosis (TB) in hematopoietic stem cell transplant (HSCT)
recipients is scant, even in countries where TB is common. We describe a case of pulmonary …

Sickle cell disease is one of the most common, life-threatening, non-communicable diseases
in the world and a major public health problem. Following the implementation of simple …

HSCT is likely to continue to increase for currently established indications. Indications and
technologies will vary between countries with limited or nonrestricted resources. The most …

Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation
(HSCT) in severe aplastic anemia (SAA) compared with mobilized peripheral blood stem …

Background The risk of developing tuberculosis (TB) in allogeneic hematopoietic stem cell
transplantation (HSCT) recipients is expected to be relatively high in an intermediate TB …

Matched-related bone marrow transplantation (BMT) may cure> 80% of low-risk children
with severe thalassemia (ST). Very long-term follow-up studies have shown how the …

Aims and objectives To establish the availability of High Efficiency Particulate Air (HEPA)‐
and non HEPA‐filtered rooms in eastern E uropean transplant centres and to investigate the …